Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3257448)

Published in World J Gastroenterol on January 14, 2012

Authors

Takehiro Kato1, Atsumasa Komori, Sung-Kwan Bae, Kiyoshi Migita, Masahiro Ito, Yasuhide Motoyoshi, Seigo Abiru, Hiromi Ishibashi

Author Affiliations

1: Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan.

Articles cited by this

Natural history and outcome in systemic AA amyloidosis. N Engl J Med (2007) 4.54

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33

Diagnosis and management of primary sclerosing cholangitis. Hepatology (2010) 3.60

Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol (2006) 2.48

Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol (2011) 2.05

Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) (2006) 1.76

Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology (2007) 1.45

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol (2006) 1.36

Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases? J Hepatol (2009) 1.17

A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc (2008) 1.09

Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. Amyloid (1999) 1.05

Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta (2006) 1.05

Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum (2006) 1.04

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford) (2005) 0.88

Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology (2011) 0.81

Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol (2010) 0.79

Articles by these authors

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48

Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst (2005) 5.32

Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med (2004) 4.05

Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64

Alkaline pH homeostasis in bacteria: new insights. Biochim Biophys Acta (2005) 2.64

Sweet's syndrome in patients with MDS and MEFV mutations. N Engl J Med (2015) 2.63

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology (2004) 2.16

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology (2007) 2.08

Hypervariable loci that enhance the discriminatory ability of newly proposed 15-loci and 24-loci variable-number tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. FEMS Microbiol Lett (2007) 1.83

Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res (2005) 1.80

The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun (2007) 1.76

The Mrp system: a giant among monovalent cation/proton antiporters? Extremophiles (2005) 1.75

The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol (2013) 1.62

Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children. Sleep (2003) 1.54

Consumption of wild boar linked to cases of hepatitis E. J Hepatol (2004) 1.54

Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol (2004) 1.52

Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 1.48

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int (2006) 1.40

Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol (2005) 1.38

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37

AID-dependent generation of resected double-strand DNA breaks and recruitment of Rad52/Rad51 in somatic hypermutation. Immunity (2003) 1.32

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32

Motility and chemotaxis in alkaliphilic Bacillus species. Future Microbiol (2009) 1.31

Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J (2008) 1.31

Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox. Circulation (2004) 1.29

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.27

Brain surface spindle cell glioma in a patient with medically intractable partial epilepsy: a variant of monomorphous angiocentric glioma? Neuropathology (2008) 1.22

Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6. Am J Med Genet A (2010) 1.20

Serial electrocardiographic findings in women with Takotsubo cardiomyopathy. Am J Cardiol (2007) 1.19

Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology (2002) 1.18

Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 1.18

Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer (2012) 1.17

Cation/proton antiporter complements of bacteria: why so large and diverse? Mol Microbiol (2009) 1.17

Thromboembolism in Takotsubo cardiomyopathy. Int J Cardiol (2008) 1.15

Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol (2003) 1.14

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol (2010) 1.13

A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion (2008) 1.13

Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int (2006) 1.12

Overexpression of heat shock protein 70 in stomach of stress-induced gastric ulcer-resistant rats. Dig Dis Sci (2003) 1.11

Three two-component transporters with channel-like properties have monovalent cation/proton antiport activity. Proc Natl Acad Sci U S A (2007) 1.10

Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int (2010) 1.10

Genome of alkaliphilic Bacillus pseudofirmus OF4 reveals adaptations that support the ability to grow in an external pH range from 7.5 to 11.4. Environ Microbiol (2011) 1.09

Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology (2005) 1.08

Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 1.08

Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology (2006) 1.07

Liver architecture, cell function, and disease. Semin Immunopathol (2009) 1.06

A Bacillus flagellar motor that can use both Na+ and K+ as a coupling ion is converted by a single mutation to use only Na+. PLoS One (2012) 1.05

Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope. PLoS One (2012) 1.05

CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun (2008) 1.04

Familial Mediterranean fever in Japan. Medicine (Baltimore) (2012) 1.04

Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol (2006) 1.04

Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol (2007) 1.04

The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer (2003) 1.03

T cell immunity in autoimmune hepatitis. Autoimmun Rev (2005) 1.03

Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology (2008) 1.03

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol (2005) 1.03

Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Transl Res (2008) 1.02

Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int (2007) 1.02

Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol (2004) 1.02

Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death. Eur J Immunol (2003) 1.02

Catalytic properties of Staphylococcus aureus and Bacillus members of the secondary cation/proton antiporter-3 (Mrp) family are revealed by an optimized assay in an Escherichia coli host. J Bacteriol (2007) 1.02

Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology (2003) 1.02

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology (2014) 1.01

Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett (2008) 1.01

SPI: a tool for incorporating gene expression data into a four-dimensional database of Caenorhabditis elegans embryogenesis. Bioinformatics (2004) 1.01

Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology (2003) 1.00

Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis. J Hepatol (2007) 1.00

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest (2005) 1.00

Mutations alter the sodium versus proton use of a Bacillus clausii flagellar motor and confer dual ion use on Bacillus subtilis motors. Proc Natl Acad Sci U S A (2008) 1.00